Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders

European Psychiatry

Volumn 26, Issue 5, 2011, Pages 284-292

  Schennach Wolff, R ^a   Seemuller F ^a   Obermeier, M ^a   Messer, T ^b   Laux, G ^c   Pfeiffer, H ^d   Naber, D ^e   Schmidt, L G ^f   Gaebel, W ^g   Klosterkotter J ^h   Heuser, I ⁱ   Maier, W ^j   Lemke, M R ^k   Ruther E ^l   Buchkremer, G ^m   Gastpar, M ⁿ   Jager M ^a   Moller H J ^a   Riedel, M ^a,o  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b District Hospital Augsburg   (Germany)

^c District Hospital Gabersee   (Germany)

^d KLINIKUM MÜNCHEN OST   (Germany)

^e UNIVERSITY OF HAMBURG   (Germany)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h UNIVERSITY OF COLOGNE   (Germany)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j UNIVERSITY OF BONN   (Germany)

^k Alsterdorf Hospital   (Germany)

^l UNIVERSITY OF GÖTTINGEN   (Germany)

^m UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

ⁿ UNIVERSITY OF DUISBURG ESSEN   (Germany)

^o Vinzenz von Paul Hospital   (Germany)

more..

Author keywords

Predictor variables; Quality of life; Remission; Response; Schizophrenia and psychosis

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; TRANQUILIZER;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; EDUCATIONAL STATUS; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGICAL WELL BEING; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCHIZOPHRENIA; SIDE EFFECT; SUBJECTIVE WELL BEING UNDER NEUROLEPTIC TREATMENT SCALE; TREATMENT RESPONSE;

ADULT; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PERSONAL SATISFACTION; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79960460531     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2009.11.005     Document Type: Article

References (49)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth edition. Washington DC, American Psychiatric Association, 1994.
2. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005, 162:441-449.
3. Bobes J., Garcia-Portilla P., Saiz P.A., Bascaran T., Bousono M. Quality of life measures in schizophrenia. Eur Psychiatry 2005, 20(Suppl. 3):S313-S317.
4. Caron J., Lecomte Y., Stip E., Renaud S. Predictors of quality of life in schizophrenia. Community Ment Health J 2005, 41:399-417.
5. Carpiniello B., Lai G.L., Pariante C.M., Carta M.G., Rudas N. Symptoms, standards of living and subjective quality of life: a comparative study of schizophrenic and depressed out-patients. Acta Psychiatr Scand 1997, 96:235-241.
6. Cooke M.A., Peters E.R., Kuipers E., Kumari V. Disease, deficit or denial? Models of poor insight in psychosis. Acta Psychiatr Scand 2005, 112:4-17.
7. Cording C. Conceptual aspects in development and implementation of basic psychiatric documentation. Psychiatr Prax 1998, 25:175-178.
8. Corrigan P.W., Buican B. The construct validity of subjective quality of life for the severely mentally ill. J Nerv Ment Dis 1995, 183:281-285.
9. Drake R.E., Ehrlich J. Suicide attempts associated with akathisia. Am J Psychiatry 1985, 142:499-501.
10. Emsley R., Rabinowitz J., Medori R. Time course for antipsychotic treatment response in first-episode schizophrenia. Am J Psychiatry 2006, 163:743-745.
11. Emsley R., Rabinowitz J., Medori R. Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates. Schizophr Res 2007, 89:129-139.
12. Fleischhacker W.W. Pharmacological treatment of schizophrenia: a review;. WPA Series Evidence and Experience in Psychiatry 2002, 75-113. John Wiley & Sons, Chichester, England. M. Maj, N. Sartorius (Eds.).
13. Franz M., Meyer T., Reber T., Gallhofer B. The importance of social comparisons for high levels of subjective quality of life in chronic schizophrenic patients. Qual Life Res 2000, 9:481-489.
14. gtsson-Tops A., Hansson L. Subjective quality of life in schizophrenic patients living in the community relationship to clinical and social characteristics. Eur Psychiatry 1999, 14:256-263.
15. gtsson-Tops A., Hansson L., Sandlund M., Bjarnason O., Korkeila J., Merinder L., et al. Subjective versus interviewer assessment of global quality of life among persons with schizophrenia living in the community: a Nordic multicentre study. Qual Life Res 2005, 14:221-229.
16. Hansson L., Bjorkman T. Are factors associated with subjective quality of life in people with severe mental illness consistent over time? A 6-year follow-up study. Qual Life Res 2007, 16:9-16.
17. Hofer A., Kemmler G., Eder U., Edlinger M., Hummer M., Fleischhacker W.W. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. J Clin Psychiatry 2004, 65:932-939.
18. Jager M., Riedel M., Messer T., Laux G., Pfeiffer H., Naber D., et al. Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders. Eur Arch Psychiatry Clin Neurosci 2007, 257:47-53.
19. Kane J.M., Fleischhacker W.W., Hansen L., Perlis R., Pikalov A., ssuncao-Talbott S. Akathisia: an updated review focusing on second-generation antipsychotics. J Clin Psychiatry 2009, 70:627-643.
20. Karow A., Pajonk F.G., Reimer J., Hirdes F., Osterwald C., Naber D., et al. The dilemma of insight into illness in schizophrenia: self- and expert-rated insight and quality of life. Eur Arch Psychiatry Clin Neurosci 2008, 258:152-159.
21. Kay S.R., Opler L.A., Lindenmayer J.P. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res 1988, 23:99-110.
22. Kinon B.J., Chen L., scher-Svanum H., Stauffer V.L., Kollack-Walker S., Sniadecki J.L., et al. Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia. Schizophr Res 2008, 102:230-240.
23. Koivumaa-Honkanen H., Honkanen R., Viinamaki H., Heikkila K., Kaprio J., Koskenvuo M. Life satisfaction and suicide: a 20-year follow-up study. Am J Psychiatry 2001, 158:433-439.
24. Lambert M., Naber D., Eich F.X., Schacht M., Linden M., Schimmelmann B.G. Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride. Acta Psychiatr Scand 2007, 115:106-113.
25. Lambert M., Schimmelmann B.G., Naber D., Schacht A., Karow A., Wagner T., et al. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry 2006, 67:1690-1697.
26. Lehman A.F., Postrado L.T., Rachuba L.T. Convergent validation of quality of life assessments for persons with severe mental illnesses. Qual Life Res 1993, 2:327-333.
27. Lingjaerde O., Ahlfors U.G., Bech P., Dencker S.J., Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 1987, Suppl. 334. [1-100:1-100].
28. Mintz AR, Addington J, Addington D. Insight in early psychosis: a 1-year follow-up. Schizophr Res 2004;67:213-7.
29. Mueser K.T., Douglas M.S., Bellack A.S., Morrison R.L. Assessment of enduring deficit and negative symptom subtypes in schizophrenia. Schizophr Bull 1991, 17:565-582.
30. Myrtek M., Foerster F. The law of initial value: a rare exception. Biol Psychol 1986, 22:227-237.
31. Naber D. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol 1995, 10(Suppl. 3):133-138.
32. Pedrelli P, McQuaid JR, Granholm E, Patterson TL, McClure F, Beck AT, et al. Measuring cognitive insight in middle-aged and older patients with psychotic disorders. Schizophr Res 2004;71:297-305.
33. Ponizovsky A.M., Grinshpoon A., Levav I., Ritsner M.S. Life satisfaction and suicidal attempts among persons with schizophrenia. Compr Psychiatry 2003, 44:442-447.
34. Putzhammer A., Perfahl M., Pfeiff L., Hajak G. Correlation of subjective well-being in schizophrenic patients with gait parameters, expert-rated motor disturbances, and psychopathological status. Pharmacopsychiatry 2005, 38:132-138.
35. R Development Core Team. A language and environment for statistical computing. URL http://w.R-project.org 2008 Vienna, Austria, Foundation for Statistical Computing. Ref Type: Computer Program.
36. Rettenbacher M.A., Hofer A., Eder U., Hummer M., Kemmler G., Weiss E.M., et al. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication. J Clin Psychiatry 2004, 65:1211-1218.
37. Ritsner M. Predicting changes in domain-specific quality of life of schizophrenia patients. J Nerv Ment Dis 2003, 191:287-294.
38. Ritsner M., Gibel A., Ratner Y. Determinants of changes in perceived quality of life in the course of schizophrenia. Qual Life Res 2006, 15:515-526.
39. Ritsner M., Ponizovsky A., Endicott J., Nechamkin Y., Rauchverger B., Silver H., et al. The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study. Eur Neuropsychopharmacol 2002, 12:31-38.
40. Schwartz R.C. Insight and illness in chronic schizophrenia. Compr Psychiatry 1998, 39:249-254.
41. Sim K, Mahendran R, Siris SG, Heckers S, Chong SA. Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression. Psychiatry Res 2004;129:141-7.
42. Skantze K., Malm U., Dencker S.J., May P.R., Corrigan P. Comparison of quality of life with standard of living in schizophrenic out-patients. Br J Psychiatry 1992, 161:797-801.
43. Sullivan G., Wells K.B., Leake B. Clinical factors associated with better quality of life in a seriously mentally ill population. Hosp Community Psychiatry 1992, 43:794-798.
44. Vandiver V.L. Quality of life, gender and schizophrenia: a cross-national survey in Canada, Cuba, and USA. Community Ment Health J 1998, 34:501-511.
45. Voruganti L.N., Heslegrave R.J., Awad A.G. Quality of life measurement during antipsychotic drug therapy of schizophrenia. J Psychiatry Neurosci 1997, 22:267-274.
46. Wehmeier PM, Kluge M, Schneider E, Schacht A, Wagner T, Schreiber W. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:703-12.
47. Weinstein M.C., Fineberg H.V. Clinical decisions analysis 1980, WB Saunders, Philadelphia, PA.
48. Wolwer W., Buchkremer G., Hafner H., Klosterkotter J., Maier W., Moller H.J., et al. German research network on schizophrenia-bridging the gap between research and care. Eur Arch Psychiatry Clin Neurosci 2003, 253:321-329.
49. Young A.S., Sullivan G., Burnam M.A., Brook R.H. Measuring the quality of outpatient treatment for schizophrenia. Arch Gen Psychiatry 1998, 55:611-617.